Modeling and simulation to optimize the design and analysis of confirmatory trials, characterize risk-benefit, and support label claims
CPT Pharmacometrics Syst Pharmacol
.
2013 Feb 27;2(2):e27.
doi: 10.1038/psp.2013.4.
Authors
S F Marshall
1
,
R Hemmings
,
F Josephson
,
M O Karlsson
,
M Posch
,
J-L Steimer
Affiliation
1
Pfizer, Pharmacometrics, Global Clinical, Pharmacology, Sandwich, UK.
PMID:
23835938
PMCID:
PMC3600757
DOI:
10.1038/psp.2013.4
No abstract available